Panacos Pharmaceuticals, Inc.
PANC · OTC
12/31/2007 | 12/31/2006 | 12/31/2005 | 12/31/2004 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $38 | $33 | $87 | $5 |
| Short-Term Investments | $14 | $28 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $2 | $1 | $0 |
| Total Curr. Assets | $53 | $63 | $89 | $5 |
| Property Plant & Equip (Net) | $1 | $2 | $2 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $1 | $1 | $0 |
| Total NC Assets | $3 | $3 | $3 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $56 | $66 | $92 | $6 |
| Liabilities | – | – | – | – |
| Payables | $3 | $3 | $2 | $3 |
| Short-Term Debt | $3 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4 | $3 | $4 | $0 |
| Total Curr. Liab. | $10 | $7 | $6 | $3 |
| LT Debt | $17 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $0 | $0 | $30 |
| Total NC Liab. | $17 | $0 | $0 | $30 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $27 | $7 | $6 | $33 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $0 | $0 |
| Retained Earnings | -$160 | -$123 | -$84 | -$25 |
| AOCI | $0 | $0 | -$0 | -$2 |
| Other Equity | $188 | $181 | $170 | $1 |
| Total Equity | $29 | $59 | $86 | -$26 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $56 | $66 | $92 | $6 |
| Net Debt | -$19 | -$33 | -$87 | -$5 |